Assignee
BIOGNOSTIK GES
DE·5 granted patents·1 pending application·80 citations·filing 1994–2006
Top patents by PatentIndex Score
6 records- 0188US7667027B2Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 2006·Granted Feb 23, 2010·15 cites·2 claims
- 0284US6455689B1Antisense-oligonucleotides for transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 1994·Granted Sep 24, 2002·49 cites·6 claims
- 0366US7563778B2Antisense oligonucleotide preparation methodBIOGNOSTIK GES·Filed 2004·Granted Jul 21, 2009·2 cites·5 claims
- 0458US6972171B1Antisense oligonucleotide preparation methodBIOGNOSTIK GES·Filed 1998·Granted Dec 6, 2005·14 cites·9 claims
- 0548US2003040499A1Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta)BIOGNOSTIK GES·Filed 2002·Application pending·0 cites
- 0628US7326783B2Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasmsBIOGNOSTIK GES·Filed 1994·Granted Feb 5, 2008·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when BIOGNOSTIK GES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →